Lazar David E., a 10% owner of Cyclacel Pharmaceuticals ($CYCC), made one open market sale of common shares in the last year, totaling $83,430, with the most recent on July 30, 2025. He had no open market purchases during this period. His sales rank 9,814th among 11,678 individual insiders, below the average sale amount of $8.6 million and 6.4 transactions.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec. 31, 2025 | Sow Good Inc. | $SOWG | Lazar David E. | Director | M | Series AA Preferred Stock | 410000 | $2.00 | 1,090,000.0000 | 12,223,599 | 27.33% | 3.35% |
| March 31, 2026 | Sow Good Inc. | $SOWG | Lazar David E. | Director | A | Common Stock | 5740000 | $0.14 | 5,740,000.0000 | 12,223,599 | 9999.99% | 46.96% |
| March 23, 2026 | Indaptus Therapeutics, Inc. | $INDP | Lazar David E. | Director | S | Series AAA Convertible Non-Redeemable Preferred Stock | 700000 | $0.00 | 0.0000 | 1,641,920 | 100.00% | 42.63% |
| March 23, 2026 | Indaptus Therapeutics, Inc. | $INDP | Lazar David E. | Director | S | Series AA Convertible Non-Redeemable Preferred Stock | 196800 | $0.00 | 103,200.0000 | 1,641,920 | 65.60% | 11.99% |
| Feb. 13, 2026 | MAINZ BIOMED N.V. | $MYNZ | Lazar David E. | Director | A | Series C Preferred Shares | 1000000 | $0.00 | 1,000,000.0000 | 2,319,353 | 9999.99% | 43.12% |
| Feb. 13, 2026 | MAINZ BIOMED N.V. | $MYNZ | Lazar David E. | Director | A | Series B Preferred Shares | 1000000 | $0.00 | 1,000,000.0000 | 2,319,353 | 9999.99% | 43.12% |
| Feb. 13, 2026 | MAINZ BIOMED N.V. | $MYNZ | Lazar David E. | Director | A | Series A Preferred Shares | 1000000 | $0.00 | 1,000,000.0000 | 2,319,353 | 9999.99% | 43.12% |
| Oct. 21, 2025 | NovaBay Pharmaceuticals, Inc. | $NBY | Lazar David E. | TenPercentOwner | M | Series D Convertible Preferred Stock | 39925 | $0.00 | 0.0000 | 5,816,204 | 100.00% | 0.69% |
| Oct. 21, 2025 | NovaBay Pharmaceuticals, Inc. | $NBY | Lazar David E. | TenPercentOwner | A | Common Stock | 6388000 | $0.00 | 6,388,000.0000 | 5,816,204 | 9999.99% | 100.00% |
| Dec. 31, 2025 | Sow Good Inc. | $SOWG | Lazar David E. | Chief Executive Officer | A | Series AA Preferred Stock | 1500000 | $2.00 | 1,500,000.0000 | 12,223,599 | 9999.99% | 12.27% |
| Dec. 18, 2025 | KALA BIO, Inc. | $KALA | Lazar David E. | Chief Executive Officer | J | Convertible Loan | 368614 | $0.00 | 0.0000 | 7,042,457 | 100.00% | 5.23% |
| Nov. 24, 2025 | KALA BIO, Inc. | $KALA | Lazar David E. | Chief Executive Officer | A | Series AA Convertible Preferred Stock | 900000 | $0.00 | 900,000.0000 | 7,042,457 | 9999.99% | 12.78% |
| Oct. 16, 2025 | NovaBay Pharmaceuticals, Inc. | $NBY | Lazar David E. | TenPercentOwner | S | Series D Convertible Preferred Stock | 441325 | $0.00 | 39,925.0000 | 5,816,204 | 91.70% | 7.59% |
| July 30, 2025 | Bio Green Med Solution, Inc. | $BGMS | Lazar David E. | TenPercentOwner | S | Common Stock | 6750 | $12.36 | 155,838.0000 | 0 | 4.15% | 0.00% |
| April 2, 2025 | LQR House Inc. | $YHC | Lazar David E. | President | A | Common Stock | 100000 | $0.00 | 100,000.0000 | 621,437 | 9999.99% | 16.09% |
| Feb. 18, 2025 | FiEE, Inc. | $FIEE | Lazar David E. | Director | S | Warrants | 2800000 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Feb. 18, 2025 | FiEE, Inc. | $FIEE | Lazar David E. | Director | A | Common Stock | 1200000 | $0.00 | 2,681,980.0000 | 0 | 80.97% | 0.00% |
| Feb. 18, 2025 | FiEE, Inc. | $FIEE | Lazar David E. | Director | S | Series A Convertible Preferred Stock | 2219447 | $0.00 | 85,910.0000 | 0 | 96.27% | 0.00% |
| Feb. 26, 2025 | Bio Green Med Solution, Inc. | $BGMS | Lazar David E. | Interim CEO | M | Series D Convertible Preferred Stock | 1745262 | $0.00 | 354,738.0000 | 0 | 83.11% | 0.00% |
| Feb. 26, 2025 | Bio Green Med Solution, Inc. | $BGMS | Lazar David E. | Interim CEO | M | Common Stock | 2650000 | $0.00 | 2,650,000.0000 | 0 | 9999.99% | 0.00% |
| Feb. 26, 2025 | Bio Green Med Solution, Inc. | $BGMS | Lazar David E. | Interim CEO | M | Common Stock | 191978820 | $0.00 | 194,628,820.0000 | 0 | 7244.48% | 0.00% |
| Feb. 26, 2025 | Bio Green Med Solution, Inc. | $BGMS | Lazar David E. | Interim CEO | S | Common Stock | 194628820 | $0.03 | 0.0000 | 0 | 100.00% | 0.00% |
| Feb. 26, 2025 | Bio Green Med Solution, Inc. | $BGMS | Lazar David E. | Interim CEO | M | Series C Convertible Preferred Stock | 1000000 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Feb. 6, 2025 | Bio Green Med Solution, Inc. | $BGMS | Lazar David E. | Interim CEO | A | Series D Convertible Preferred Stock | 2100000 | $0.00 | 2,100,000.0000 | 0 | 9999.99% | 0.00% |
| Dec. 26, 2024 | FiEE, Inc. | $FIEE | Lazar David E. | Director | P | Common Stock | 1456980 | $0.03 | 1,481,980.0000 | 0 | 5827.92% | 0.00% |
| Nov. 21, 2024 | LQR House Inc. | $YHC | Lazar David E. | President | S | Common Stock | 821818 | $0.00 | 280,000.0000 | 154,035 | 74.59% | 100.00% |
| Nov. 25, 2024 | LQR House Inc. | $YHC | Lazar David E. | President | S | Common Stock | 280000 | $0.00 | 0.0000 | 154,035 | 100.00% | 100.00% |
| Oct. 21, 2024 | FiEE, Inc. | $FIEE | Lazar David E. | Director | A | Series A Convertible Preferred Stock | 305357 | $0.00 | 2,305,357.0000 | 0 | 15.27% | 0.00% |
| April 23, 2024 | CapForce Inc. | $CFOR | Lazar David E. | Chief Executive Officer | A | Series E Convertible Preferred Stock | 150000 | $1.00 | 550,000.0000 | 787,832 | 37.50% | 19.04% |
| July 30, 2024 | CapForce Inc. | $CFOR | Lazar David E. | Chief Executive Officer | S | Series E Convertible Preferred Stock | 550000 | $0.00 | 0.0000 | 787,832 | 100.00% | 69.81% |
| April 5, 2024 | CapForce Inc. | $CFOR | Lazar David E. | Chief Executive Officer | A | Series E Convertible Preferred Stock | 200000 | $1.00 | 200,000.0000 | 787,832 | 9999.99% | 25.39% |
| April 23, 2024 | CapForce Inc. | $CFOR | Lazar David E. | Chief Executive Officer | P | Series E Convertible Preferred Stock | 150000 | $1.00 | 550,000.0000 | 787,832 | 37.50% | 19.04% |
| April 11, 2024 | CapForce Inc. | $CFOR | Lazar David E. | Chief Executive Officer | A | Common Stock | 100000 | $0.00 | 100,000.0000 | 787,832 | 9999.99% | 12.69% |
| April 5, 2024 | CapForce Inc. | $CFOR | Lazar David E. | Chief Executive Officer | P | Series E Convertible Preferred Stock | 200000 | $1.00 | 9,600,000.0000 | 787,832 | 2.13% | 25.39% |
| Jan. 29, 2024 | FiEE, Inc. | $FIEE | Lazar David E. | Director | P | Series A Convertible Preferred Stock | 2000000 | $1.40 | 2,000,000.0000 | 0 | 9999.99% | 0.00% |
| Jan. 29, 2024 | FiEE, Inc. | $FIEE | Lazar David E. | Director | P | Warrants | 2800000 | $0.00 | 2,800,000.0000 | 0 | 9999.99% | 0.00% |
| Jan. 22, 2024 | FiEE, Inc. | $FIEE | Lazar David E. | Director | A | Common Stock | 25000 | $0.00 | 25,000.0000 | 0 | 9999.99% | 0.00% |